Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
915 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hypoglycemic Agents" (915 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C;   Drug: glyburide
2 Recruiting Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
Conditions: Type 2 Diabetes Mellitus;   Bariatric Surgery;   Biliopancreatic Diversion
Interventions: Procedure: biliopancreatic diversion;   Drug: antidiabetics
3 Recruiting White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis
Conditions: Chronic Periodontitis;   Diabetes Mellitus, Type 2
Interventions: Procedure: ADT+FD;   Procedure: FD
4 Recruiting IMS® DIAREG Diabetes Registry
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: antidiabetic treatment (ATC A10B)
5 Recruiting Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Condition: Hypoglycemia
Intervention: Procedure: euglycemic and hypoglycemic clamp
6 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Biological: MSC
7 Recruiting Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Liraglutide;   Drug: Placebo
8 Recruiting Oral Antidiabetic Agents in Pregnancy
Condition: Gestational Diabetes
Interventions: Drug: Metformin;   Drug: Glyburide
9 Recruiting Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Alogliptin
10 Unknown  The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
Conditions: Type 2 Diabetes;   Hypercholesterolemia
Interventions: Dietary Supplement: Cinnamonforce;   Dietary Supplement: Placebo
11 Recruiting Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability
Conditions: Type 2 Diabetes Mellitus;   Menopause;   Osteoporosis;   Osteopenia
Interventions: Drug: Vildagliptin;   Drug: Gliclazide MR
12 Recruiting Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Placebo;   Other: Mixed meal test;   Drug: Liraglutide
13 Recruiting Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Conditions: Prediabetes;   Obesity
Interventions: Drug: Exenatide;   Drug: Saxagliptin;   Drug: Pioglitazone;   Other: Placebo
14 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: Placebo;   Drug: Exenatide
15 Unknown  A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Repaglinide
16 Recruiting A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin;   Drug: Placebo
17 Recruiting A Trial Investigating the Efficacy and Safety of Insulin Detemir Versus Insulin NPH in Combination With Metformin and Diet/Exercise in Children and Adolescents With Type 2 Diabetes Insufficiently Controlled on Metformin With or Without Other Oral Antidiabetic Drug(s) With or Without Basal Insulin
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin detemir;   Drug: insulin NPH
18 Recruiting Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
Condition: Type 2 Diabetes
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo
19 Recruiting Observational Registry for Basal Insulin Treatment Study (ORBIT)
Condition: Diabetes
Intervention:
20 Recruiting Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Conditions: Diabetes Mellitus, Type 2;   Hypertension
Interventions: Drug: Canagliflozin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years